University Health Network, Toronto: Pancreatic Neoplasms trials
The registry lists 14 Pancreatic Neoplasms studies with University Health Network, Toronto as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 7Phase 3 1No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic CancerNot yet recruitingNCT07665684Phase 1/2
- Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac PainRecruitingNCT07636382Not applicable
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- MR Guidance for Liver and PancreasRecruitingNCT03582189
- Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic CancerActive, not recruitingNCT06783140Phase 2/3
- Province of Ontario Strategy for Personalized Management of Pancreatic Cancer TrialActive, not recruitingNCT05927298
- A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic CancerCompletedNCT02481635Phase 1/2
- A Study of GSK2256098 and Trametinib in Advanced Pancreatic CancerCompletedNCT02428270Phase 2
- A Study of Pancreatic Cancer in Xenografts From Liver MetastasesCompletedNCT01774643
- A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic CancerCompletedNCT01542177
- Study of Intratumoral Hypoxia Using Pre-operative Administration of PimonidazoleCompletedNCT01248637
- Phase II Trial of Erlotinib in Advanced Pancreatic CancerCompletedNCT00497224Phase 2
- 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00078975Phase 2
- Perifosine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00053924Phase 2